Energy improvements may occur indirectly through better glycaemic control and weight reduction, whilst fatigue often results from gastrointestinal side effects or reduced caloric intake
For example, nurses may need to take blood samples for testing, and imaging technicians can help to gauge disease severity
What makes tirzepatide fundamentally different is that it doesnt just act on GLP-1it also targets GIP, a second incretin hormone with distinct effects
Yes, research protocols typically involve defined cycles
These increase additions in cost
Discontinuation should be considered when: Vomiting is severe, persistent, and unresponsive to management strategies Symptoms significantly impair quality of life or ability to function Dehydration or malnutrition develops Complications such as pancreatitis are suspected or confirmed (Ozempic should not be restarted if pancreatitis is confirmed) [1] [2] The patient wishes to discontinue despite medical advice to continue Alternative GLP-1 receptor agonists with different pharmacokinetic profiles may be better tolerated if Ozempic is discontinued